Fractyl Health today announced positive preclinical proof-of-concept data in an animal model for its gene therapy delivery platform for treating type 2 diabetes. The company, which develops the Revita diabetes reversal procedure, evaluated its Rejuva program. Rejuva, a novel device and AAV-mediated delivery platform, delivers gene therapy directly targeting the pancreas. This potentially embeds multiple […]
Researchers tout AI-based diabetes onset prediction method
Scientists at Klick Applied Sciences say they discovered a way to use a continuous glucose monitor (CGM) as a diabetes screening tool. The scientists determined that they can use artificial intelligence (AI) to screen and prevent the chronic health condition. They used machine learning and 12 hours of data from CGMs to determine whether a […]
BD opens $38.6M medication management manufacturing plant in Mexico
BD (NYSE:BDX) announced recently that it inaugurated a new $38.6 million manufacturing facility in Tijuana, Mexico. Government officials from Mexico and the state of Baja California joined in the opening of the medication management plant. BD plans for the facility to produce devices and technologies that improve medication safety within healthcare settings. According to a […]
BD warns on cybersecurity risk with BodyGuard infusion pumps
The U.S. Cybersecurity and Infrastructure Security Agency (CISA) today issued an advisory regarding infusion pumps from BD (NYSE:BD). CISA’s advisory concerns the BD BodyGuard infusion pumps. They may contain a vulnerability in the form of a missing protection mechanism for an alternate hardware interface. No known public exploits specifically target this vulnerability, CISA said. Attackers […]
Dexcom G6 CGMs win reimbursement coverage in Japan
Terumo announced today that the Japanese medical insurance system expanded reimbursement coverage for the Dexcom G6 CGM. Japan’s medical insurance system introduced a new category titled “C150.” It makes a wider range of people with diabetes eligible to receive reimbursement for the Dexcom G6 continuous glucose monitor (CGM) in Japan. Dexcom develops and manufactures the […]
Data supports digital diabetes program from Carbon Health
Carbon Health today announced patient data from its digital diabetes program, highlighting improved outcomes. San Francisco-based Carbon Health designed its endocrinologist-led platform to integrate with primary care. A certified team of diabetes educators supports the completely virtual platform. It offers accessibility to patients with no waiting or travel time involved. Carbon Health’s electronic health record […]
PharmaJet wins NIH grant to evaluate needle-free delivery of HPV immunization
PharmaJet announced today that it received a grant worth $800,000-plus from the NIH to evaluate its needle-free injection system. Golden, Colorado-based PharmaJet picked up a Phase II grant from the NIH (National Institutes of Health). It allows the company to evaluate the immunogenicity of the intradermal administration of human papillomavirus virus (HPV) vaccine. The study […]
GE HealthCare, Ulrich ink deal to offer multi-dose contrast media injector in U.S.
GE HealthCare today announced an agreement with Ulrich Medical to offer a GE HealthCare branded contrast media injector in the U.S. The CT motion multi-dose syringeless injector delivers iodinated contrast media for computed tomography (CT) imaging procedures. It helps to reduce procedure setup time and increase patient throughput by eliminating time-consuming preparation steps. Additionally, it […]
Ypsomed, CamDiab launch first automated insulin dosing system with Abbott FreeStyle Libre 3
Ypsomed announced that its mylife Loop now has authorization to work with the Abbott FreeStyle Libre 3 sensor in Germany. The Ypsomed mylife YpsoPump combines with the CamDiab mylife CamAPS FX algorithm and FreeStyle Libre 3. Together, they form an intelligent and automated insulin delivery (AID) system for people with type 1 diabetes. Users can […]
Bionaut Labs closes $43M Series B for robotic drug delivery tech
Robotic drug delivery technology developer Bionaut Labs announced today that it closed a Series B financing round worth $43.2 million. Los Angeles-based Bionaut Labs uses microscale robots to deliver drugs for treating central nervous system (CNS) diseases and disorders. Through magnetic propulsion, the company’s Bionauts can navigate the human body and deliver drugs locally. The […]